Repressors NFI and NFY participate in organ-specific regulation of von willebrand factor promoter activity in transgenic mice

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 30, Issue 7, 2010, Pages 1423-1429

  Nassiri, Marjan ^a   Liu, Ju ^b   Kulak, Stephen ^a   Uwiera, Richard R E ^a   Aird, William C ^b   Ballermann, Barbara J ^a   Jahroudi, Nadia ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

endothelium; gene expression; molecular biology; promoter; transcription; vascular biology; von Willebrand factor

Indexed keywords

NUCLEAR FACTOR I; NUCLEAR FACTOR Y; VON WILLEBRAND FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE ACTIVATION; GENE EXPRESSION REGULATION; HEART; HEMOSTASIS; IMMUNOHISTOCHEMISTRY; KIDNEY; LUNG; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN LOCALIZATION; REPRESSOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE SPECIFICITY; TRANSGENIC MOUSE; VASCULAR ENDOTHELIUM;

ANIMALS; BINDING SITES; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; CORONARY VESSELS; ENDOTHELIAL CELLS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; KIDNEY; LAC OPERON; LUNG; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION; NFI TRANSCRIPTION FACTORS; NUCLEIC ACID CONFORMATION; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; VON WILLEBRAND FACTOR; YY1 TRANSCRIPTION FACTOR;

EID: 77953963085     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.110.206680     Document Type: Article

References (23)

1. Aird WC. Phenotypic heterogeneity of the endothelium, I: structure, function, and mechanisms. Circ Res. 2007;100:158-173.
2. Aird WC. Phenotypic heterogeneity of the endothelium, II: representative vascular beds. Circ Res. 2007;100:174-190.
3. Fish JE, Marsden PA. Endothelial nitric oxide synthase: insight into cell-specific gene regulation in the vascular endothelium. Cell Mol Life Sci. 2006;63:144-162.
4. Aird WC, Jahroudi N, Weiler-Guettler H, Rayburn HB, Rosenberg RD. Human von Willebrand factor gene sequences target expression to a subpopulation of endothelial cells in transgenic mice. Proc Natl Acad Sci USA. 1995;92:4567-4571.
5. Prandini MH, Dreher I, Bouillot S, Benkerri S, Moll T, Huber P. The human VE-cadherin promoter is subjected to organ-specific regulation and is activated in tumour angiogenesis. Oncogene. 2005;24:2992-3001.
6. Jahroudi N, Lynch DC. Endothelial-cell-specific regulation of von Wil-lebrand factor gene expression. Mol Cell Biol. 1994;14:999-1008.
7. Jahroudi N, Schmaier A, Srikanth S, Mahdi F, Lutka FA, Bowser R. Von Willebrand factor promoter targets the expression of amyloid beta protein precursor to brain vascular endothelial cells of transgenic mice. J Alzhei-mers Dis. 2003;5:149-158.
8. Aird WC, Edelberg JM, Weiler-Guettler H, Simmons WW, Smith TW, Rosenberg RD. Vascular bed-specific expression of an endothelial cell gene is programmed by the tissue microenvironment. J Cell Biol. 1997; 138:1117-1124.
9. Kleinschmidt AM, Nassiri M, Stitt MS, Wasserloos K, Watkins SC, Pitt BR, Jahroudi N. Sequences in intron 51 of the von Willebrand factor gene target promoter activation to a subset of lung endothelial cells in transgenic mice. J Biol Chem. 2008;283:2741-2750.
10. Peng Y, Jahroudi N. The NFY transcription factor inhibits von Wille-brand factor promoter activation in non-endothelial cells through recruitment of histone deacetylases. J Biol Chem. 2003;278:8385-8394.
11. Wang X, Peng Y, Ma Y, Jahroudi N. Histone H1-like protein participates in endothelial cell-specific activation of the von Willebrand factor promoter. Blood. 2004;104:1725-1732.
12. Peng Y, Jahroudi N. The NFY transcription factor functions as a repressor and activator of the von Willebrand factor promoter. Blood. 2002;99: 2408-2417.
13. Schwachtgen JL, Janel N, Barek L, Duterque-Coquillaud M, Ghysdael J, Meyer D, Kerbiriou-Nabias D. Ets transcription factors bind and transac-tivate the core promoter of the von Willebrand factor gene. Oncogene. 1997;15:3091-3102.
14. Jahroudi N, Ardekani AM, Greenberger JS. An NF1-like protein functions as a repressor of the von Willebrand factor promoter. J Biol Chem. 1996;271:21413-21421.
15. Schwachtgen JL, Remacle JE, Janel N, Brys R, Huylebroeck D, Meyer D, Kerbiriou-Nabias D. Oct-1 is involved in the transcriptional repression of the von Willebrand factor gene promoter. Blood. 1998;92:1247-1258.
16. Peng Y, Stewart D, Li W, Hawkins M, Kulak S, Ballermann B, Jahroudi N. Irradiation modulates association of NF-Y with histone-modifying cofactors PCAF and HDAC. Oncogene. 2007;26:7576-7583.
17. Chaudhry AZ, Lyons GE, Gronostajski RM. Expression patterns of the four nuclear factor I genes during mouse embryogenesis indicate a potential role in development. Dev Dyn. 1997;208:313-325.
18. Pham NL, Franzen A, Levin EG. NF1 regulatory element functions as a repressor of tissue plasminogen activator expression. Arterioscler Thromb Vasc Biol. 2004;24:982-987.
19. Ouellet S, Vigneault F, Lessard M, Leclerc S, Drouin R, Guerin SL. Transcriptional regulation of the cyclin-dependent kinase inhibitor 1A (p21) gene by NFI in proliferating human cells. Nucleic Acids Res. 2006;34:6472-6487.
20. Mason S, Piper M, Gronostajski RM, Richards LJ. Nuclear factor one transcription factors in CNS development. Mol Neurobiol. 2009;39:10-23.
21. Steele-Perkins G, Plachez C, Butz KG, Yang G, Bachurski CJ, Kinsman SL, Litwack ED, Richards LJ, Gronostajski RM. The transcription factor gene Nfib is essential for both lung maturation and brain development. Mol Cell Biol. 2005;25:685-698.
22. Pusztaszeri MP, Seelentag W, Bosman FT. Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. J Histochem Cytochem. 2006;54: 385-395.
23. Yamamoto K, de Waard V, Fearns C, Loskutoff DJ. Tissue distribution and regulation of murine von Willebrand factor gene expression in vivo. Blood. 1998;92:2791-2801.